Pregnant women, prescription, and fetal risk-Reference-Cited by-同舟云学术

Pregnant women, prescription, and fetal risk

Published:2020 Issue: Volume: Page:377-389
ISSN:0072-9752
Container-title:Handbook of Clinical Neurology
language:
Short-container-title:

Author:

Eléfant Elisabeth,Hanin Cyril,Cohen David

Publisher

Elsevier

Reference76 articles.

1. Safety of selective serotonin reuptake inhibitors in pregnancy: a review of current evidence;Alwan;CNS Drugs,2016

2. Controlling drug delivery across the placenta;Audus;Eur J Pharm Sci,1999

3. The developmental origins of adult disease;Barker;Eur J Epidemiol,2003

4. Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics;Bourget;Archiv Francaises De Pediatrie,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pregnancy blues;Case Studies: Stahl's Essential Psychopharmacology;2024-04-30

2. Scope of using hollow fibers as a medium for drug delivery;Fiber and Textile Engineering in Drug Delivery Systems;2023

3. ПЕРИНАТАЛЬНЫЕ СТРЕССОРНЫЕ ВОЗДЕЙСТВИЯ КАК ФАКТОР НАРУШЕНИЯ РАЗВИТИЯ И ФУНКЦИЙ НЕРВНОЙ СИСТЕМЫ: ОБЗОР МОДЕЛЕЙ IN VIVO;Журнал высшей нервной деятельности им. И.П. Павлова;2022-07

4. Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems;Drug Safety;2021-10-06

5. Avenir de l’enfant : les chances et les aléas du neurodéveloppement;Bulletin de l'Académie Nationale de Médecine;2021-10